Streetbeat News

Stock Prices

HRTX

Heron Therapeutics' shares surged following the announcement of better-than-expected Q4 adjusted EPS results and the issuance of optimistic FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:58 pm

NATR

Nature's Sunshine Products (NATR) shares are trading higher following the announcement of better-than-expected Q4 adjusted EPS results and the issuance of optimistic FY24 net sales guidance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:56 pm

SNCR

Synchronoss Technologies (NASDAQ:SNCR) reported Q4 earnings with an EPS of $-0.85, missing estimates by -750.0% and a revenue decrease of $20.23 million from the previous year. The company had previously beaten EPS estimates in Q3 2023 but experienced a 16.0% share price drop the following day.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:55 pm

CYRX

CryoPort (NASDAQ:CYRX) reported Q4 earnings with an EPS of $-0.3, missing estimates by -3.0% against an expected $-0.29. Revenue decreased by $3.10 million compared to the same period last year. Despite missing EPS estimates last quarter, the share price increased by 10.0% the following day. Historical performance shows mixed results in meeting EPS and revenue estimates over the past year.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:55 pm

AWRE

Aware Inc. (AWRE) shares have declined following the announcement of a year-over-year decrease in its Q4 earnings per share (EPS) results.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:54 pm

SIGA

SIGA Therapeutics' stock is trading higher following the announcement of improved financial results for Q4, showing a year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:52 pm

CLOV

Clover Health Investments (NASDAQ:CLOV) reported Q4 earnings with a per-share loss of $(0.15), missing the $(0.14) estimate, but surpassed sales estimates with $510.25M against the expected $480.25M. This represents a decrease in losses and a significant drop in sales compared to the same period last year.

Portfolio Pulse from Happy Mohamed

March 12, 2024 | 8:52 pm

OPAL

OPAL Fuels Inc. (NASDAQ:OPAL) announced a significant change in its share structure, with Fortistar LLC exchanging 71.5 million shares of Class D common stock for an equal number of Class B common stock, reducing its voting control. This move is anticipated to make OPAL's Class A common stock eligible for inclusion in stock market indices, potentially affecting its attractiveness to investors, although inclusion and its impact on stock price are uncertain.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:50 pm

SWIM

Latham Group projects its Q1 2024 sales to be between $98M and $104M, significantly lower than the estimated $130.468M. This forecast suggests a potential downturn in the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

March 12, 2024 | 8:50 pm

RXT

Rackspace Tech (NASDAQ:RXT) reported Q4 earnings, beating estimates with an EPS of $-0.03 against an expected $-0.04, but saw a revenue decline of $67.30 million year-over-year. The company's past performance shows mixed results in earnings beats and misses, with guidance for Q1 2024 projecting earnings between $-0.14 and $-0.12 per share.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 8:50 pm